Wolinsky JS - Search Results

1

Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis.

Brod SA, Kerman RH, Nelson LD, Marshall GD Jr, Henninger EM, Khan M, Jin R, Wolinsky JS. Brod SA, et al. Among authors: wolinsky js. Mult Scler. 1997 Feb;3(1):1-7. doi: 10.1177/135245859700300101. Mult Scler. 1997. PMID: 9160341 Clinical Trial.

2

Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.

Wolinsky JS, McCarthy M, Allen-Cannady O, Moore WT, Jin R, Cao SN, Lovett A, Simmons D. Wolinsky JS, et al. J Virol. 1991 Aug;65(8):3986-94. doi: 10.1128/JVI.65.8.3986-3994.1991. J Virol. 1991. PMID: 1712855 Free PMC article.

3

Immune studies in human immunodeficiency virus infection with myasthenia gravis: a case report.

Nath A, Kerman RH, Novak IS, Wolinsky JS. Nath A, et al. Among authors: wolinsky js. Neurology. 1990 Apr;40(4):581-3. doi: 10.1212/wnl.40.4.581. Neurology. 1990. PMID: 2138717

4

Proton magnetic resonance spectroscopy in multiple sclerosis.

Wolinsky JS, Narayana PA, Fenstermacher MJ. Wolinsky JS, et al. Neurology. 1990 Nov;40(11):1764-9. doi: 10.1212/wnl.40.11.1764. Neurology. 1990. PMID: 2172865

5

Antibody response to rubella virus structural proteins in multiple sclerosis.

Nath A, Wolinsky JS. Nath A, et al. Among authors: wolinsky js. Ann Neurol. 1990 May;27(5):533-6. doi: 10.1002/ana.410270513. Ann Neurol. 1990. PMID: 2360794

6

Effect of cyclosporine on rubella virus-specific immune responses in chronic progressive multiple sclerosis.

Nath A, Wolinsky JS, Kerman RH. Nath A, et al. Among authors: wolinsky js. J Neuroimmunol. 1989 Apr;22(2):143-8. doi: 10.1016/0165-5728(89)90045-3. J Neuroimmunol. 1989. PMID: 2925842 Clinical Trial.

7

Serial immune evaluation of cyclosporine- and placebo-treated multiple sclerosis patients.

Kerman RH, Wolinsky JS, Nath A, Sears ES Jr. Kerman RH, et al. Among authors: wolinsky js. J Neuroimmunol. 1988 Jul;18(4):325-31. doi: 10.1016/0165-5728(88)90053-7. J Neuroimmunol. 1988. PMID: 2968363 Clinical Trial.

8

Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.

McCarthy M, Lovett A, Kerman RH, Overstreet A, Wolinsky JS. McCarthy M, et al. Among authors: wolinsky js. J Virol. 1993 Feb;67(2):673-81. doi: 10.1128/JVI.67.2.673-681.1993. J Virol. 1993. PMID: 7678302 Free PMC article.

9

Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis.

Brod SA, Khan M, Bright J, Sriram S, Marshall GD Jr, Henninger EM, Kerman RH, Wolinsky JS. Brod SA, et al. Among authors: wolinsky js. Ann Neurol. 1995 Apr;37(4):546-9. doi: 10.1002/ana.410370418. Ann Neurol. 1995. PMID: 7717692

10

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.

Brod SA, Marshall GD Jr, Henninger EM, Sriram S, Khan M, Wolinsky JS. Brod SA, et al. Among authors: wolinsky js. Neurology. 1996 Jun;46(6):1633-8. doi: 10.1212/wnl.46.6.1633. Neurology. 1996. PMID: 8649562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters